y******8
发帖数: 1764 | 1 NCI ($5.1B): FY10 payline at 15th percentile for Type 1/2 R01s, 20th for new
investigator R01s; 15th for R21s; impact score up to 30 for R03s; impact
score up to 29 for R15s
NCI cleared concepts
NCI program contacts
NIAID ($4.8B): Interim FY11 payline at 8th percentile for established and
12th percentile for new/ESI investigators; FY10 payline for R01 at 11th
percentile and at 16th for new investigators; R03 at impact score 31, R15 at
22, R21 at 31, F31 at 28, F32 at 28, K other than K99 at 26, ... 阅读全帖 |
|
v***l
发帖数: 2623 | 2 要具体看你交哪个 institute。 NIAMS的R21现在是不鼓励没有R01的人申请，鼓吹R21
是high impact, high risk。几年前大家都是在申R01前先申R21，因为那时的Key word
是high risk。尤其R21是不鼓励new investigator申的，至少NIAMS的是写在网页上的。
275k
have |
|
s*******7
发帖数: 399 | 3 here you go,
-------------------------------------
KO8
NCCAM Other Mechanisms - Direct K08 1 0 0.0% $0
NCI Other Mechanisms - Direct K08 54 22 40.7% $3,464,862
NEI Other Mechanisms - Direct K08 9 8 88.9% $1,472,390
NHLBI Other Mechanisms - Direct K08 78 25 32.1% $3,211,290
NIA Other Mechanisms - Direct K08 7 3 42.9% $450,683
NIAAA Other Mechanisms - Direct K08 3 1 33.3% $177,736 ... 阅读全帖 |
|
|
C*****h
发帖数: 926 | 5 这是NIH 2010年的统计数据，自己看吧。
NIH Success Rates for New and Renewal R01 Applications in FY2010 ?
Sorted by Institute/Center
NIH Institutes/Centers Activity Code Application Type Number of
Applications Reviewed Number of Applications Awarded Success Rate Total
Funding
FIC R01 New 27 8 29.6% $864,592
NCCAM R01 New
Renewal 183
6 18
1 9.8%
16.7% $8,373,967
$349,501
NCI R01 New
Renewal 3518
775 573
261 16.3%
33.7% $229,173,642
$98,... 阅读全帖 |
|
|
p*******7
发帖数: 322 | 7 NIAMS这个payline是个内部临时payline，就是说先fund这批7 %ile 以内的，今年最终
的payline应该和去年差不多，你的9 %ile 应该没问题。祝你好运！ |
|
m**i
发帖数: 355 | 8 今天收到新的信息： At this time NIAMS’ FY18 Funding Plan continues to
include a 12% reduction on competing grants. We do not anticipate this
changing as a result of the Omnibus Appropriations Bill.
看来不会拿回来那12%了。 |
|
|
|
b********h
发帖数: 2481 | 11 如果你是收到了email让你叫JIT，那是一个很好的信号，只有intend to fund才会通知
交JIT。
预先祝贺你，K99的竞争很激烈，去年NIAMS的K99的payline好像是14，无法想象谁能拿
到这样的分数。 |
|
n*****a
发帖数: 265 | 12 http://www.knowbuddhism.info/2009/02/dynamic-meditation-luang-p
Biography of the Master
Luangpor Teean Jittasubho (1911-1988), or Phan Intapew, was born on
September 5, 1911, at Buhom, Amphur Chiengkhan in the Province of Loei.
He was the son of Jeen and Som Intapew. His father died when he was
young. Since there was no school in the small village of Buhom, he did
not have a formal education in his childhood. The boy, like the rest
of the children in the village, had to help his mother in runnin... 阅读全帖 |
|
s******y
发帖数: 28562 | 13 冯建峰
冯建峰，男，“复旦-浩清”特聘教授，复旦大学计算系统生物学中心主任。曾任
英国华威大学教授，并担任计算系统生物学中心和复杂性中心副主任，德国洪堡学者，
长江特聘教授，剑桥Babraham所生物数学研究室副主任。主要研究兴趣为计算系统生物
学，在神经元脉冲发放的随机性、因果关系的研究、从单个神经元到生...
陈棣
陈棣，男，上海中医药大学与国际华人骨研学会联合研究中心主任、美国罗切斯特
大学医学中心骨科系教授、美国NIH基金和美国NIAMS基金等项目评审专家。1982年毕业
于天津医科大学，1992年获美国路易斯维尔大学药理学/毒理学博士学位。曾任美国罗
切斯特大学医学中心骨科系助理教授、副教授，美国骨科研究学会(ORS)主题委员会...
陈春麟
陈春麟，男，上海药理学会药物代谢动力学专业委员会副主任委员及上海浦东生物
医药学会副理事长等职务，同时还受聘为中国药科大学生命科学院客座教授。 1994年
毕业于美国俄克拉何马州立大学，获药理学及毒理学博士学位。毕业后从事多年药物的
药理、毒理及生物化学研究，在设计心血管药物、抗艾滋和抗癌新药的药代动力学和...
黄蓬
黄蓬，男，中山大 |
|
w**********e
发帖数: 557 | 14 Fiscal Year Activity Code NIH Institute / Center Number of
Applications Reviewed Number of Applications Awarded Success Rate2
Total Funding
2012 K22 NCI 41 6 14.6% $995,087
2012 K22 NHLBI 4 0 0.0% $0
2012 K22 NIAID 51 15 29.4% $2,392,292
2012 K22 NIMH 1 1 100.0% $324,000
2012 K22 NIAAA 2 0 0.0% $0
2012 K22 NIMHD 2 2 100.0% $375,025
2012 K22 NLM 2 1 50.0% ... 阅读全帖 |
|
